This observation is consistent with the report of Rosenblatt et al. [4], who observed an increased frequency of PB CD4+PD-1+ T cells in myeloma patients with advanced active disease as a result of chronic antigen stimulation, thus contributing to tumor-induced suppression of T cell responses. The gene discussed is CD4; the disease is neoplasm.